Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinsons Disease
NEJM 382:1926-1932, Schweitzer, J.S.,et al, 2020
Long-Term Clinical Outcomes After Fetal Cell Transplantation in Parkinson Disease Implications for the Future of Cell Therapy
JAMA 311:617-618, Bega, D. & Krainc, D., 2014
Tai Chi and Postural Stability in Patients with Parkinsons Disease
NEJM 366:511-519, Li,F.,et al, 2012
What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008
Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004
Stem Cells and Neurological Disease
JNNP 74:553-557, Barker,R.A.,et al, 2003
Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002
What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000
Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996
The Use of Fetal Tissue in Research on Parkinson's Disease
NEJM 327:1591-1592, Kassirer,J.P.&Angell,M., 1992
A Brain Transplant that Works
Lancet 335:445-446, , 1990
Dose-Dependent Memory Impairment in Parkinson's Disease
Neurol 39:438-440, Huber,S.J.,et al, 1989
The Ethical Use of Human Fetal Tissue in Medicine
NEJM 320:1093-1096, Greely,H.T.,et al, 1989
The Politics of Transplantation of Human Fetal Tissue
NEJM 320:1079-1082, Annas,G.J.&Elias,S., 1989
Drug-Induced Alzheimerism
Arch Neurol 45:356-357, Kurlan,R.&Como,P., 1988
Update on Parkinson Disease
NY State J Med, 87:147-1531987., Lieberman,A.N., 1987
Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979